177 related articles for article (PubMed ID: 15998331)
1. Non-invasive preoperative assessment of basal cell carcinoma of nodular and superficial types.
Kuzmina N; Talme T; Lapins J; Emtestam L
Skin Res Technol; 2005 Aug; 11(3):196-200. PubMed ID: 15998331
[TBL] [Abstract][Full Text] [Related]
2. Differentiation among basal cell carcinoma, benign lesions, and normal skin using electric impedance.
Beetner DG; Kapoor S; Manjunath S; Zhou X; Stoecker WV
IEEE Trans Biomed Eng; 2003 Aug; 50(8):1020-5. PubMed ID: 12892329
[TBL] [Abstract][Full Text] [Related]
3. Electrical impedance of nodular basal cell carcinoma: a pilot study.
Emtestam L; Nicander I; Stenström M; Ollmar S
Dermatology; 1998; 197(4):313-6. PubMed ID: 9873166
[TBL] [Abstract][Full Text] [Related]
4. Basal cell carcinoma: histological classification and body-site distribution.
Raasch BA; Buettner PG; Garbe C
Br J Dermatol; 2006 Aug; 155(2):401-7. PubMed ID: 16882181
[TBL] [Abstract][Full Text] [Related]
5. Clinically normal atopic skin vs. non-atopic skin as seen through electrical impedance.
Nicander I; Ollmar S
Skin Res Technol; 2004 Aug; 10(3):178-83. PubMed ID: 15225268
[TBL] [Abstract][Full Text] [Related]
6. Discordant expression of desmoglein 2 and 3 at the mRNA and protein levels in nodular and superficial basal cell carcinoma revealed by immunohistochemistry and fluorescent in situ hybridization.
Pietkiewicz P; Gornowicz-Porowska J; Bowszyc-Dmochowska M; Jagielska J; Helak-Łapaj C; Kaczmarek E; Dmochowski M
Clin Exp Dermatol; 2014 Jul; 39(5):628-35. PubMed ID: 24934917
[TBL] [Abstract][Full Text] [Related]
7. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes.
McCormack CJ; Kelly JW; Dorevitch AP
Arch Dermatol; 1997 May; 133(5):593-6. PubMed ID: 9158412
[TBL] [Abstract][Full Text] [Related]
8. Comparative morphometric analysis of primary versus recurrent basal cell carcinoma and of histological subtypes. Significance of morphometry of the nuclei.
Bierhoff E; Appel K; Appel T; Buettner R; Wardelmann E
Anticancer Res; 2003; 23(3B):2697-700. PubMed ID: 12894560
[TBL] [Abstract][Full Text] [Related]
9. Monitoring efficacy of cryotherapy for superficial basal cell carcinomas with in vivo reflectance confocal microscopy: a preliminary study.
Ahlgrimm-Siess V; Horn M; Koller S; Ludwig R; Gerger A; Hofmann-Wellenhof R
J Dermatol Sci; 2009 Jan; 53(1):60-4. PubMed ID: 18829267
[TBL] [Abstract][Full Text] [Related]
10. [Desmoplastic trichoepithelioma: a clinicopathological study, including a comparison with morpheiform basal cell carcinoma].
Mitcov M; Scrivener Y; Cribier B
Ann Dermatol Venereol; 2009; 136(6-7):501-7. PubMed ID: 19560610
[TBL] [Abstract][Full Text] [Related]
11. Correlation of histological subtypes of basal cell carcinoma with age, sex and distribution of skin lesions: a five-year study at Ramathibodi Hospital.
Puavilai S; Sirapan S
J Med Assoc Thai; 2002 May; 85(5):560-4. PubMed ID: 12188385
[TBL] [Abstract][Full Text] [Related]
12. Preoperative assessment of basal cell carcinoma using conventional fluorescence diagnosis.
Neus S; Gambichler T; Bechara FG; Wöhl S; Lehmann P
Arch Dermatol Res; 2009 Apr; 301(4):289-94. PubMed ID: 18979108
[TBL] [Abstract][Full Text] [Related]
13. Detection of basal cell carcinoma using electrical impedance and neural networks.
Dua R; Beetner DG; Stoecker WV; Wunsch DC
IEEE Trans Biomed Eng; 2004 Jan; 51(1):66-71. PubMed ID: 14723495
[TBL] [Abstract][Full Text] [Related]
14. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
15. Differences in the vascular patterns of basal and squamous cell skin carcinomas explain their differences in clinical behaviour.
Chin CW; Foss AJ; Stevens A; Lowe J
J Pathol; 2003 Jul; 200(3):308-13. PubMed ID: 12845626
[TBL] [Abstract][Full Text] [Related]
16. The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial.
Brinkhuizen T; Frencken KJ; Nelemans PJ; Hoff ML; Kelleners-Smeets NW; Zur Hausen A; van der Horst MP; Rennspiess D; Winnepenninckx VJ; van Steensel MA; Mosterd K
J Am Acad Dermatol; 2016 Jul; 75(1):126-34. PubMed ID: 27067393
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of clinical diagnosis of skin lesions.
Heal CF; Raasch BA; Buettner PG; Weedon D
Br J Dermatol; 2008 Sep; 159(3):661-8. PubMed ID: 18616767
[TBL] [Abstract][Full Text] [Related]
18. Management of basal cell carcinoma by surveyed dermatologists in Scotland.
Gudi V; Ormerod AD; Dawn G; Green C; MacKie RM; Douglas WS; Gupta G;
Clin Exp Dermatol; 2006 Sep; 31(5):648-52. PubMed ID: 16901303
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinoma.
Lallas A; Tzellos T; Kyrgidis A; Apalla Z; Zalaudek I; Karatolias A; Ferrara G; Piana S; Longo C; Moscarella E; Stratigos A; Argenziano G
J Am Acad Dermatol; 2014 Feb; 70(2):303-11. PubMed ID: 24268311
[TBL] [Abstract][Full Text] [Related]
20. Histological characteristics of basal cell carcinoma of the eyelid.
Paavilainen V; Aaltonen M; Tuominen J; Saari KM
Ophthalmic Res; 2007; 39(1):45-8. PubMed ID: 17164577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
